Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of BAT8008 for recurrent or metastatic rare lower genital tract and perianal cancers
CTR20262942Phase 2Active
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Jul 2026
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BAT8008 in Lower Genital Tract Cancer, perianal cancer, sponsored by Bio-Thera Solutions, Ltd.. Started Jul 2026; status: active.
02
Drugs
BAT8008
03
Conditions
Lower Genital Tract Cancerperianal cancer
Beyond the preview
Go deeper on CTR20262942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262942.